NCT05487703View on ClinicalTrials.gov

A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting

CompletedOBSERVATIONAL
Enrollment

318

Participants

Timeline

Start Date

November 14, 2022

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions
Arthritis, Rheumatoid
Trial Locations (1)

Unknown

Pfizer, Casablanca

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05487703 - A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting | Biotech Hunter | Biotech Hunter